About Sentiss Pharma
Sentiss Pharma is a company based in Gurugram (India) founded in 1990 by Deepak Bahri. It operates as a B2B and Contract Manufacturing. The company has 689 employees as of March 31, 2023. Sentiss Pharma offers products and services including Ophthalmic Products, Inhalational Products, ENT Products, and Specialty Products. Sentiss Pharma operates in a competitive market with competitors including Annexon, Aldeyra, Lyra Therapeutics, Nicox and Decibel Therapeutics, among others.
- Headquarter Gurugram, India
- Employees 689 as on 31 Mar, 2023
- Founders Deepak Bahri
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sentiss Pharma Private Limited
- Date of Incorporation 13 Jan, 1994
- Jurisdiction Delhi, India
-
Annual Revenue
$75.7 M (USD)47.02as on Mar 31, 2023
-
Net Profit
$20.84 M (USD)114.05as on Mar 31, 2023
-
EBITDA
$28.14 M (USD)106.43as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
689
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sentiss Pharma
Sentiss Pharma offers a comprehensive portfolio of products and services, including Ophthalmic Products, Inhalational Products, ENT Products, and Specialty Products.
Treats eye conditions with quality pharmaceutical solutions
Delivers medications for nebulization and breathing therapies
Provides treatments for ear, nose, and throat ailments
Offers innovative solutions for various medical specialties
People of Sentiss Pharma
Unlock access to complete
Funding Insights of Sentiss Pharma
Detailed funding history for Sentiss Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sentiss Pharma
Investment portfolio details for Sentiss Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sentiss Pharma
Detailed financials for Sentiss Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sentiss Pharma Comparisons
Peer comparison for Sentiss Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sentiss Pharma
Sentiss Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Annexon, Aldeyra, Lyra Therapeutics, Nicox and Decibel Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of antibodies to treat complement-mediated neurodegenerative diseases
|
|
| Locked | Locked | Locked |
Drug candidates for immune-mediated diseases are developed by Aldeyra.
|
|
| Locked | Locked | Locked |
Small molecule therapeutics for ENT diseases are developed.
|
|
| Locked | Locked | Locked |
Nitric oxide-based therapeutics for glaucoma and eye conditions are developed.
|
|
| Locked | Locked | Locked |
Medicines are developed to protect, repair, and restore hearing capacity.
|
|
| Locked | Locked | Locked |
Mobile SDK developed for app engagement and monetization strategies.
|
Detailed competitors of Sentiss Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sentiss Pharma
Complete news archive for Sentiss Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sentiss Pharma
Sentiss Pharma was founded in 1990.
Sentiss Pharma is headquartered in Gurugram, India. It is registered at Gurugram, Haryana, India.
Deepak Bahri is the current CEO of Sentiss Pharma. They have also founded this company.
As of Mar 31, 2023, the latest employee count at Sentiss Pharma is 689.
Annual revenue of Sentiss Pharma is $75.7M as on Mar 31, 2023.
Sentiss Pharma is a pharmaceutical company established in 1990, focusing on creating value through generic and innovative eye care, inhalational, ENT, and specialty products. It operates primarily from India, with offices in Gurgaon and manufacturing in Himachal Pradesh, while serving global customers via affiliates. The company emphasizes research, development, quality manufacturing, and social initiatives in health and education.
Sentiss Pharma's top competitors include Annexon, Decibel Therapeutics and Alimera Sciences.
Sentiss Pharma offers Ophthalmic Products, Inhalational Products, ENT Products, and Specialty Products.